BSR/PDA Standard 02-201x Cryopreservation Standard Available for Public Comment

Share Article

This is the second of PDA's standards to reach public comment phase.

This standard will assist both commercial and clinical groups with their cryopreservation efforts.

The Parenteral Drug Association (PDA) today announced the availability of BSR/PDA Standard 02-201x, Cryopreservation of Cells for Use in Cell Therapies and Regenerative Medicine Manufacturing for public comment. To receive a copy of this draft standard, email PDA at standards@pda.org. The public comments period concludes September 7, 2020 EDT. There is no charge for the draft standard.

To better harmonize cryopreservation of advanced therapies, including cell and gene therapies, PDA convened a working group comprising experts from academia, industry, and governmental regulatory bodies to compile and draft current best practices into a single reference document. This standard will assist both commercial and clinical groups with their cryopreservation efforts.

On August 7, 2020 BSR/PDA Standard 04-201x, Phage Retention Nomenclature Rating for Small and Large Virus Retentive Filters will also be released for public comment.

For more information about PDA’s role in standards development, visit: https://www.pda.org/scientific-and-regulatory-affairs/pda-ansi.

Find answers to standard development questions: https://www.pda.org/scientific-and-regulatory-affairs/pda-standards-frequently-asked-questions or reach out to standards@pda.org.

About PDA – Connecting People, Science and Regulation®
The Parenteral Drug Association (PDA) is the leading global provider of science, technology and regulatory information and education for the pharmaceutical and biopharmaceutical community. Founded in 1946 as a nonprofit organization, PDA is committed to developing scientifically sound, practical technical information and resources to advance science and regulation through the expertise of over 10,500 members worldwide. PDA is an ANSI accredited Standards Developing Organization. Go to http://www.pda.org/footer/about-pda to learn more.

Share article on social media or email:

View article via:

Pdf Print

Contact Author

Walter Morris
PDA, Inc.
+1 (301) 656-5900 Ext: 148
Email >
@PDAonline
Follow >
Visit website